461 related articles for article (PubMed ID: 27581518)
1. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
[TBL] [Abstract][Full Text] [Related]
2. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
Li X; Gonias SL; Campana WM
Glia; 2005 Sep; 51(4):254-65. PubMed ID: 15812815
[TBL] [Abstract][Full Text] [Related]
3. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
4. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
Wu P; Zhang N; Wang X; Zhang C; Li T; Ning X; Gong K
PLoS One; 2012; 7(9):e45122. PubMed ID: 23028796
[TBL] [Abstract][Full Text] [Related]
5. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
6. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
[TBL] [Abstract][Full Text] [Related]
9. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
Pérès EA; Valable S; Guillamo JS; Marteau L; Bernaudin JF; Roussel S; Lechapt-Zalcman E; Bernaudin M; Petit E
Exp Cell Res; 2011 Oct; 317(16):2321-32. PubMed ID: 21749867
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
11. Role of erythropoietin receptor expression in malignant melanoma.
Mirmohammadsadegh A; Marini A; Gustrau A; Delia D; Nambiar S; Hassan M; Hengge UR
J Invest Dermatol; 2010 Jan; 130(1):201-10. PubMed ID: 19536148
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin promotes hair shaft growth in cultured human hair follicles and modulates hair growth in mice.
Kang BM; Shin SH; Kwack MH; Shin H; Oh JW; Kim J; Moon C; Moon C; Kim JC; Kim MK; Sung YK
J Dermatol Sci; 2010 Aug; 59(2):86-90. PubMed ID: 20554434
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
16. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
18. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
19. Lack of functional erythropoietin receptors of cancer cell lines.
Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin receptor contributes to melanoma cell survival in vivo.
Kumar SM; Zhang G; Bastian BC; Arcasoy MO; Karande P; Pushparajan A; Acs G; Xu X
Oncogene; 2012 Mar; 31(13):1649-60. PubMed ID: 21860424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
